COVID-19 update: Covid-19-associated coagulopathy

J Thromb Thrombolysis. 2020 Jul;50(1):54-67. doi: 10.1007/s11239-020-02134-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anticoagulants / therapeutic use
  • Antiviral Agents / therapeutic use
  • Betacoronavirus / drug effects
  • Betacoronavirus / pathogenicity*
  • Blood Coagulation Disorders / blood
  • Blood Coagulation Disorders / drug therapy
  • Blood Coagulation Disorders / epidemiology
  • Blood Coagulation Disorders / virology*
  • Blood Coagulation* / drug effects
  • Coronavirus Infections / blood
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / virology*
  • Host-Pathogen Interactions
  • Humans
  • Pandemics
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / virology*
  • Practice Guidelines as Topic
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome
  • Viral Load

Substances

  • Anticoagulants
  • Antiviral Agents

Supplementary concepts

  • COVID-19
  • COVID-19 drug treatment
  • severe acute respiratory syndrome coronavirus 2